IgG Antibodies, SARS-CoV-2 Load, and Prognostic Indicators in Patients with Severe and Mild COVID-19 in Japan

J Nippon Med Sch. 2021 Sep 1;88(4):380-383. doi: 10.1272/jnms.JNMS.2021_88-417. Epub 2020 Nov 30.

Abstract

We assessed the association of severity of coronavirus disease 2019 (COVID-19) with acute respiratory syndrome coronavirus 2 (SARS-CoV-2) load, IgG antibody level, and prognostic indicators.Twenty-one patients hospitalized with COVID-19 were classified as having severe or mild disease on the basis of average respiratory rate during hospitalization (severe: ≥22 breaths/min; mild: <22 breaths/min). Viral load in nasopharyngeal samples, blood levels of C-reactive protein (CRP), lymphocytes, and D-dimer on admission and plasma immunoglobulin G (IgG) index on Day 7±2 after symptom onset were compared in relation to disease severity. Seven patients had severe disease and 14 had mild disease. Those with severe disease had a significantly higher IgG index (median: 3.75 vs 0.56, p=0.01) and CRP (median: 8.6 vs 1.0 mg/dL, p<0.001) and D-dimer levels (median: 1.65 vs 0.75 μg/mL; p=0.002) and a significantly lower lymphocyte count (median: 1,176 vs 666 cells/μL, p=0.005) and viral load (median: 8.7×106 vs 2.3×104 copies/mL, p=0.005). Furthermore, time from symptom onset to virus disappearance was significantly longer in severe patients (median: 24 vs 17 days, p=0.03). A high IgG index in the early phase of the disease was associated with severe disease and might serve as a prognostic indicator.

Keywords: COVID-19; IgG index; SARS-CoV-2; prognostic indicators; viral load.

MeSH terms

  • Adult
  • Aged
  • Antibodies, Viral / blood*
  • Biomarkers / blood
  • COVID-19 / blood
  • COVID-19 / diagnosis*
  • COVID-19 / therapy
  • COVID-19 / virology
  • COVID-19 Drug Treatment
  • COVID-19 Nucleic Acid Testing*
  • COVID-19 Serological Testing*
  • Female
  • Hospitalization
  • Host-Pathogen Interactions
  • Humans
  • Immunoglobulin G / blood*
  • Japan
  • Male
  • Middle Aged
  • Oxygen Inhalation Therapy
  • Predictive Value of Tests
  • Prognosis
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / pathogenicity*
  • Severity of Illness Index
  • Time Factors
  • Viral Load*

Substances

  • Antibodies, Viral
  • Biomarkers
  • Immunoglobulin G